OUP (Osage University Partners) logo

OUP (Osage University Partners)

North America, Pennsylvania, United States, Bala Cynwyd

Description

OUP is a venture capital fund investing in start-ups that commercialize university research.

Investor Profile

OUP (Osage University Partners) has made 214 investments, with 5 in the past 12 months and 5% as lead.

Stage Focus

  • Series A (36%)
  • Series B (25%)
  • Series C (14%)
  • Series Unknown (8%)
  • Series D (7%)
  • Seed (5%)
  • Post Ipo Equity (2%)
  • Series E (2%)

Country Focus

  • United States (97%)
  • United Kingdom (1%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical
  • Pharmaceutical
  • Biopharma
  • Medical Device
  • Manufacturing
  • Software
  • Artificial Intelligence (Ai)
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does OUP (Osage University Partners) frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 25
HBM Healthcare Investments
Europe, Zug, Switzerland, Zug
Co-Investments: 11
Pfizer Venture Investments
North America, New York, United States, New York
Co-Investments: 11
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 12
5AM Ventures
North America, California, United States, Menlo Park
Co-Investments: 13
New Enterprise Associates
North America, California, United States, Menlo Park
Co-Investments: 14
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 14
U.S. Venture Partners
North America, California, United States, Menlo Park
Co-Investments: 16
The Column Group
North America, California, United States, San Francisco
Co-Investments: 13
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 14

Which angels does OUP (Osage University Partners) often collaborate with?

PK
North America, Tennessee, United States, Nashville
Shared Deals: 2
BD
North America, Kentucky, United States, Louisville
Shared Deals: 2
KF
North America, Texas, United States, Houston
Shared Deals: 2
Shared Deals: 2
HT
Europe, Noord-Brabant, The Netherlands, Tilburg
Shared Deals: 2
Shared Deals: 2
TF
North America, Texas, United States, Dallas
Shared Deals: 2
BG
North America, Washington, United States, Seattle
Shared Deals: 3
GB
Europe, England, United Kingdom, London
Shared Deals: 2
DR
North America, Texas, United States, Houston
Shared Deals: 2

What are some of recent deals done by OUP (Osage University Partners)?

MicroTransponder

Dallas, Texas, United States

MicroTransponder is a medical device company that develops and commercializes neurostimulation devices to treat neurological diseases.

Health CareMedicalMedical Device
Series FMar 12, 2025
Amount Raised: $65,000,000
Overland AI

Seattle, Washington, United States

Overland AI is a manufacturer and developer of autonomous navigation for off-road autonomous vehicles.

Artificial Intelligence (AI)Autonomous VehiclesMachine LearningRoboticsSoftware
Series AJan 13, 2025
Amount Raised: $32,000,000
VeraDermics

New Haven, Connecticut, United States

VeraDermics is a dermatology company that creates novel drug delivery mechanisms for a pain-free cure for skin conditions such as warts.

Health CarePharmaceuticalTherapeutics
Series BDec 11, 2024
Amount Raised: $75,000,000
Xscape Photonics

New York, New York, United States

Xscape Photonics provides photonic chips for high-speed connections in high-performance computing systems and data centers.

Artificial Intelligence (AI)Data CenterInformation TechnologySemiconductorSimulation
Series AOct 15, 2024
Amount Raised: $44,000,000
Quantum Circuits

New Haven, Connecticut, United States

Quantum Circuits is developing and commercializing quantum computing technology that utilizes superconducting quantum circuits.

ComputerManufacturingQuantum ComputingSoftware
Series BMay 31, 2024
Amount Raised: $60,000,000
Q32 Bio

Cambridge, Massachusetts, United States

Q32 Bio is a biotechnology company that develops treatments for patients with severe autoimmune and inflammatory diseases.

BiotechnologyHealth CareMedicalTherapeutics
Post Ipo EquityMar 25, 2024
Amount Raised: $42,000,000
Quintessent

Goleta, California, United States

Quintessent is a Santa Barbara start-up that commercializes quantum dot-based lasers and photonic integrated circuits.

Artificial Intelligence (AI)Information TechnologyLaserMachine LearningSemiconductor
SeedMar 14, 2024
Amount Raised: $11,595,997
Nocion Therapeutics

Cambridge, Massachusetts, United States

Nocion Therapeutics is a developer of novel pharmaceuticals intended to treat the conditions arising from neurogenic inflammation.

BiotechnologyHealth CareMedical
Series BMar 4, 2024
Amount Raised: $62,000,000
AssetWatch

Westerville, Ohio, United States

AssetWatch is a deployable, remote, end-to-end condition monitoring solution providing predictive insight to enable proactive maintenance.

Big DataIndustrial AutomationInternet of ThingsMachine LearningPredictive Analytics
Series BFeb 21, 2024
Amount Raised: $38,000,000
BioAge Labs

Richmond, California, United States

BioAge Labs is a clinical-stage biotechnology company that develops therapeutics to treat obesity and metabolic diseases.

BiopharmaBiotechnologyLife ScienceTherapeutics
Series DFeb 13, 2024
Amount Raised: $170,000,000